I kēia lā, ua hoʻolaha ka American Lung Association i kahi hoʻolaha hou e hoʻonui i ka ʻike o ka nānā ʻana i ka maʻi kanesa a me ka hana e hōʻoia i ka uhi ʻana o nā polokalamu ʻinikua i nā alakaʻi hou e hoʻonui ana i ka pono screening ma waena o ka lāhui.

Ma Malaki 2021, ua hoʻonui ka US Preventative Services Task Force (USPSTF) i nā alakaʻi no ka nānā ʻana i ka maʻi kanesa o ka maʻi maʻi e hoʻopili i nā poʻe mai 50 a 80 mau makahiki i loaʻa i ka mōʻaukala puhi paka he 20 mau makahiki a ua puhi a ua haʻalele paha i loko o nā makahiki he 15 i hala. I kēia manawa, ʻoi aku ka ʻoi aku o ka pālua o ka helu o ʻAmelika ʻeleʻele a me Brown no ka nānā ʻana. Eia kekahi, kokoke i ka ʻelua o ka nui o nā wahine i kūpono no ka nānā ʻana ma lalo o nā alakaʻi hou.

"ʻOi aku ma mua o 14 miliona mau kānaka i kēia manawa no ka nānā ʻana i ka maʻi kanesa o ka maʻi, no laila he mea koʻikoʻi i kēia poʻe ke komo i kēia screening ho'ōla ola ma o Medicare a i ʻole kā lākou papahana ʻinikua pilikino," wahi a Harold Wimmer, National President a CEO o ka American Lung Association . "ʻO nā alakaʻi hoʻomaʻamaʻa ʻana i ka maʻi maʻi maʻi maʻi he mea koʻikoʻi i mua i ka hoʻoponopono ʻana i nā ʻokoʻa lāhui e pili ana i ka maʻi kanesa. ʻAʻole hiki ke ʻike ʻia ka poʻe ʻAmelika ʻeleʻele me ka maʻi maʻi maʻi maʻi i ka wā mua, ʻoi aku ka liʻiliʻi o ka loaʻa ʻana o ka lāʻau lapaʻau, a ʻoi aku ka liʻiliʻi o ka loaʻa ʻana o kekahi lāʻau lapaʻau i hoʻohālikelike ʻia me nā ʻAmelika keʻokeʻo. Nui nā ʻAmelika ʻeleʻele a me Brown ʻaʻole i kūpono i ka nānā ʻana i ka maʻi maʻi maʻi maʻi i kēia manawa i kēia manawa i nā koina i hoʻonui ʻia a he mea koʻikoʻi loa ia no lākou e kamaʻilio me kā lākou mea mālama olakino e pili ana i ka nānā ʻana.

Ma ka lā 10 o Pepeluali, ua hoʻolaha ka Centers for Medicare and Medicaid Services (CMS) i kāna hōʻano hou ʻana i kāna mau kuhikuhi no ka nānā ʻana i ka maʻi kanesa o ka maʻi maʻi no ka poʻe i uhi ʻia e Medicare e like me nā alakaʻi USPSTF (ʻo nā alakaʻi CMS no nā makahiki 50-77 ma mua o nā alakaʻi USPSTF. o nā makahiki 50-80). Ma muli o ka Affordable Care Act, ʻo ka hapa nui o nā hoʻolālā ʻinikua pilikino e koi ʻia e uhi i ka nānā ʻana i ka maʻi kanesa o ka maʻi no ka poʻe i kēia manawa i ka pilikia nui ma lalo o nā koina USPSTF no nā makahiki hoʻolālā e hoʻomaka ana ma hope o Malaki 31, 2022.

'O ka ma'i 'a'ai 'o ia ka mea pepehi ma'i 'a'ai nui ma 'Amelika, akā aia ka mana'olana. Hoʻohana ʻia ka hōʻike ʻana i ka maʻi maʻi ʻāʻī e ʻike koke i ka maʻi kanesa i ka wā e hiki ke hoʻōla ʻia. Inā loaʻa ka maʻi kanesa ma mua o ka laha ʻana, hiki ke ola i ʻelima mau makahiki a ʻoi aʻe paha i 60%. ʻO ka mea pōʻino, ʻaʻole i hoʻohana ʻia ka nānā ʻana i ka maʻi kanesa. Ma ka ʻāina, ʻo 5.7% wale nō o ka poʻe i kūpono ke nānā ʻia.

Ma o kahi haʻawina palena ʻole mai AstraZeneca, ke hana nei ka American Lung Association e hoʻonui i ka ʻike no ka nānā ʻana i ka maʻi maʻi maʻi maʻi, ʻoi aku hoʻi no nā ʻAmelika ʻeleʻele a me Brown a me nā wahine.

He aha e lawe ʻia mai kēia ʻatikala:

On February 10, the Centers for Medicare and Medicaid Services (CMS) announced that it updated its lung cancer screening eligibility guidelines for people covered by Medicare to be similar to the USPSTF guidelines (CMS guidelines are for ages 50-77 instead of the USPSTF guidelines of ages 50-80).
As a result of the Affordable Care Act, most private insurance plans are required to cover lung cancer screening for those now at high risk under the USPSTF criteria for plan years beginning after March 31, 2022.
I kēia lā, ua hoʻolaha ka American Lung Association i kahi hoʻolaha hou e hoʻonui i ka ʻike o ka nānā ʻana i ka maʻi kanesa a me ka hana e hōʻoia i ka uhi ʻana o nā polokalamu ʻinikua i nā alakaʻi hou e hoʻonui ana i ka pono screening ma waena o ka lāhui.